| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 308,800 | 266,200 | 204,600 | 250,200 | | Cost of Revenue | 271,400 | 253,300 | 204,400 | 274,800 | | | Gross Profit | 37,400 | 12,900 | 200 | (24,600) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,500 | 23,400 | 27,300 | 26,000 | | Non Recurring |
-
| 2,800 | (3,700) | 295,600 | | Others | 22,200 | 18,900 | 19,100 | 20,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,100) | (32,200) | (42,500) | (366,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,200 | 13,400 | 7,500 | (7,500) | | Earnings Before Interest And Taxes | (53,300) | (18,800) | (35,000) | (373,700) | | Interest Expense | (32,900) | 21,100 | 11,800 | 12,800 | | Income Before Tax | (20,400) | (39,900) | (46,800) | (386,500) | | Income Tax Expense | (10,500) | (16,000) | (19,200) | (48,300) | | Minority Interest |
-
|
-
|
-
| 200 | | | | Net Income From Continuing Ops | (12,700) | (27,300) | (30,200) | (339,400) | | | Non-recurring Events | | Discontinued Operations | (200) | (2,300) | (400) | (1,100) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,100) | (29,600) | (30,600) | (340,500) | | Preferred Stock And Other Adjustments | (500) | 300 | 200 |
-
| | | Net Income Applicable To Common Shares | ($12,600) | ($29,300) | ($30,400) | ($340,500) |
|
0.90% Nasdaq 
Income Statement
